These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3333881)

  • 1. Aspects of anticoagulant action: a review of the pharmacology, metabolism and toxicology of warfarin and congeners.
    Sutcliffe FA; MacNicoll AD; Gibson GG
    Rev Drug Metab Drug Interact; 1987; 5(4):225-72. PubMed ID: 3333881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pesticide resistance in wild mammals--mechanisms of anticoagulant resistance in wild rodents.
    Ishizuka M; Tanikawa T; Tanaka KD; Heewon M; Okajima F; Sakamoto KQ; Fujita S
    J Toxicol Sci; 2008 Aug; 33(3):283-91. PubMed ID: 18670159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulant-resistant rats: possible control by the use of the chloro analog of vitamin K 1 .
    Suttie JW
    Science; 1973 May; 180(4087):741-3. PubMed ID: 4702571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative pharmacokinetics of vitamin K antagonists: warfarin, phenprocoumon and acenocoumarol.
    Ufer M
    Clin Pharmacokinet; 2005; 44(12):1227-46. PubMed ID: 16372822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Warfarin resistance in a French strain of rats.
    Lasseur R; Longin-Sauvageon C; Videmann B; Billeret M; Berny P; Benoit E
    J Biochem Mol Toxicol; 2005; 19(6):379-85. PubMed ID: 16421894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin K in hereditary resistance to oral anticoagulant drugs.
    O'Reilly RA
    Am J Physiol; 1971 Nov; 221(5):1327-30. PubMed ID: 5124275
    [No Abstract]   [Full Text] [Related]  

  • 7. Low warfarin resistance frequency in Norway rats in two cities in China after 30 years of usage of anticoagulant rodenticides.
    Ma X; Wang D; Li N; Liu L; Tian L; Luo C; Cong L; Feng Z; Liu XH; Song Y
    Pest Manag Sci; 2018 Nov; 74(11):2555-2560. PubMed ID: 29667309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of coumarin action: sensitivity of vitamin K metabolizing enzymes of normal and warfarin-resistant rat liver.
    Hildebrandt EF; Suttie JW
    Biochemistry; 1982 May; 21(10):2406-11. PubMed ID: 6807339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hereditary warfarin resistance.
    Diab F; Feffer S
    South Med J; 1994 Mar; 87(3):407-9. PubMed ID: 8134868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Warfarin withdrawal. Pharmacokinetic-pharmacodynamic considerations.
    Palareti G; Legnani C
    Clin Pharmacokinet; 1996 Apr; 30(4):300-13. PubMed ID: 8983860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Warfarin and other coumarin derivatives: pharmacokinetics, pharmacodynamics, and drug interactions.
    Wittkowsky AK
    Semin Vasc Med; 2003 Aug; 3(3):221-30. PubMed ID: 15199454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of warfarin resistance and liver microsomal vitamin K epoxide reductase activity in rats.
    MacNicoll AD
    Biochim Biophys Acta; 1985 May; 840(1):13-20. PubMed ID: 3995080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Warfarin therapy: influence of pharmacogenetic and environmental factors on the anticoagulant response to warfarin.
    Siguret V; Pautas E; Gouin-Thibault I
    Vitam Horm; 2008; 78():247-64. PubMed ID: 18374198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The genetic basis of resistance to anticoagulants in rodents.
    Pelz HJ; Rost S; Hünerberg M; Fregin A; Heiberg AC; Baert K; MacNicoll AD; Prescott CV; Walker AS; Oldenburg J; Müller CR
    Genetics; 2005 Aug; 170(4):1839-47. PubMed ID: 15879509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytochrome P450-mediated warfarin metabolic ability is not a critical determinant of warfarin sensitivity in avian species: In vitro assays in several birds and in vivo assays in chicken.
    Watanabe KP; Kawata M; Ikenaka Y; Nakayama SM; Ishii C; Darwish WS; Saengtienchai A; Mizukawa H; Ishizuka M
    Environ Toxicol Chem; 2015 Oct; 34(10):2328-34. PubMed ID: 25959534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The characterization of potent novel warfarin analogs.
    Kerr JS; Li HY; Wexler RS; Robinson AJ; Robinson CS; Boswell GA; Krauthauser C; Harlow PP
    Thromb Res; 1997 Oct; 88(2):127-36. PubMed ID: 9361366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic mechanisms for hypersensitivity and resistance to the anticoagulant Warfarin.
    Linder MW
    Clin Chim Acta; 2001 Jun; 308(1-2):9-15. PubMed ID: 11412812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High clearance of (S)-warfarin in a warfarin-resistant subject.
    Hallak HO; Wedlund PJ; Modi MW; Patel IH; Lewis GL; Woodruff B; Trowbridge AA
    Br J Clin Pharmacol; 1993 Mar; 35(3):327-30. PubMed ID: 8471414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of hepatic warfarin metabolism activity in rodenticide-resistant black rats (Rattus rattus) in Tokyo by in situ liver perfusion.
    Takeda K; Ikenaka Y; Tanaka KD; Nakayama SMM; Tanikawa T; Mizukawa H; Ishizuka M
    Pestic Biochem Physiol; 2018 Jun; 148():42-49. PubMed ID: 29891376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The biochemical basis of warfarin therapy.
    Suttie JW
    Adv Exp Med Biol; 1987; 214():3-16. PubMed ID: 3310547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.